If approved by the FDA, this 5-in-1 investigational candidate could provide the broadest meningococcal serogroup coverage.
Contagion Editorial Team
Advertisement
Articles by Contagion Editorial Team
In doing so, the country met the new target of the World Health Organization.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Julie Khlevner, MD, AGAF, explains the impact of the FDA approval of linaclotide for pediatric IBS-C
2
Safety, tolerability of tenapanor in pediatric IBS-C patients, with Thomas Wallach, MD
3
Odevixibat demonstrates sustained pruritus and bile acid improvements in FIC1 deficiency
4
Wesley Kufel, PharmD, discusses doxycycline for post-exposure prevention of Lyme disease in young children
5
